Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 8, 2007, Pages 913-918

  Hausken, Anne Margrethe ^a   Skurtveit, Svetlana ^a   Tverdal, Aage ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Anxiolytics; General population; Hypnotics; Mortality; Smoking

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NORWAY; PAIN; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS;

ADULT; ANTI-ANXIETY AGENTS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; LIFE STYLE; MALE; MORTALITY; NORWAY; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 34548312505     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1417     Document Type: Article

References (25)

1. Health Statistics in the Nordic Countries 2001 [Helsestatistik for de nordiske lande 2001]. 66: 2003. 2003. København, Nordic Medico Statistical Committee (NOMESCO).
2. Rønning M. Drug Consumption in Norway 1998-2002. [Legemiddelforbruket Norge 1998-2002] (25th edn), Norwegian Institute of Public Health: Oslo, 2003.
3. Grytten L. Alcohol and Drugs in Norway 98 [Rusmidler Norge 98]. The Norwegian Directorate for the Prevention of Alcohol and Drug Problems: and the National Institute for Alcohol and Drug Research: Oslo, 1998.
4. Isacson D, Carsjo K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: an eight-year follow-up. J Clin Epidemiol 1992; 45(4): 429-436.
5. Laurier C, Dumas J, Gregoire JP. Factors related to benzodiazepine use in Quebec - secondary analysis of survey data. J Pharmacoepidemiol 1992; 2(4): 73-86.
6. van Hulten R, Leulkens HG, Bakker A. Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci 1998; 20(2): 78-82.
7. Bruk av benzodiazepiner. Konsensuskonferanse. Piene R, Stordahl A, editors. Rapport nr. 10. 1996. Oslo, Norges Forsknings-råd.
8. Rosvold EO, Vaglum P, Moum T. Use of minor tranquilizers among Norwegian physicians. A nation-wide comparative study. Soc Sci Med 1998; 46(4-5): 581-590.
9. Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time - a 13-year follow-up in a Swedish community. Soc Sci Med 1997; 44(12): 1871-1880.
10. Helseundersøkelsene i Østfold 1985 og 1988 og i Aust-Agder 1986 og 1989 [The Health Surveys in Østfold 1985 and 1988 and in Aust-Agder 1986 and 1989]. National Health Screening Service: Oslo, 1997.
11. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979; 634: 1-70.
12. Bjartveit K, Foss OP, Gjervig T. The cardiovascular disease study in Norwegian counties. Results from first screening. Acta Med Scand Suppl 1983; 675: 1-184.
13. Allgulander C, Borg S, Vikander B. A 4-6-year follow-up of 50 patients with primary dependence on sedative and hypnotic drugs. Am J Psychiatry 1984; 141(12): 1580-1582.
14. van Hulten R, Teeuw KB, Bakker A, Leufkens HG. Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J Clin Pharmacol 2003; 58(10): 689-694.
15. Skurtveit S, Abotnes B, Christophersen AS. Drugged driving in Norway with benzodiazepine detection. Forensic Sci Int 2002; 125: 75-82.
16. Hausken AM, Skurtveit S, Christophersen AS. Mortality among subjects previously apprehended for driving under the influence of traffic - hazardous medicinal drugs. Drug Alcohol Depend 2005; 79(3): 423-429.
17. Drummer OH. Benzodiazepines - effects on human performance and behaviour. Forensic Sci Rev 2002; 14(1): 2-14.
18. van Hulten R, Teeuw KB, Bakker A, Leufkens HG. Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J Clin Pharmacol 2003; 58(10): 689-694.
19. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/ or antidepressant use. Ann Epidemiol 1997; 7(8): 568-574.
20. Bond AJ, Lader MH, da Silveira JCC. Aggression. Individual differences, alcohol and benzodiazepines. Maudsley Monographs 39, Psychology Press: London, 1997.
21. Hall RC, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 1981; 11(Suppl 1): 99S-104S.
22. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5(3): 239-244.
23. Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. J Clin Epidemiol 2000; 53(12): 1222-1229.
24. Furu K, Straume B, Thelle D. Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol 1997; 50(3): 341-349.
25. Furu K, Skurtveit S, Rosvold E. Drug use questions in Norwegian health surveys - response rate and agreement between specific and open-ended questions. Nor J Epidemiol 2003; 13: 147-154.